The Global Pharmaceutical Gelatin Market size is expected to reach $1.6 billion by 2028, rising at a market growth of 5.5% CAGR during the forecast period.
Gelatin is a protein extracted from animal raw materials. It is found in abundance and is obtained by partial hydrolysis of collagen. With the presence of a high concentration of protein in connective tissues, it is composed of eighteen amino acids. The properties and functions of gelatin when it acts as a polydisperse polymer make it extensively applicable to the pharma and food industries.
With the rising demand for capsules across the world, gelatin has become an ingredient without which it is hard for pharma and many food industries to survive. Be it in the manufacturing of capsules or tablets or as a component of wound dressings, hemostatic sponges, or blood volume replacement; gelatin has shown its versatility in applicability in the medicine and pharmaceutical industry.
In the production of hard capsules and soft-gels; gelatin is used as an inactive substance that serves as a medium for an active substance. The cost associated with the production of gelatin is significantly less, and the process of making gelatin is not much complex. Also, it has active pharmaceutical ingredient (API) dissolution rates.
Pharmaceutical gelatin provides various technical benefits as compared to excipients such as HMPC, made for hard capsules, and modified starch for soft-gels. Additionally, it comes without an e-number, making it a unique excipient. Following ISO technical specifications on definitions and technical criteria, gelatin is considered a natural ingredient. It is also used in the manufacturing of medical devices.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
Gelatin is a protein extracted from animal raw materials. It is found in abundance and is obtained by partial hydrolysis of collagen. With the presence of a high concentration of protein in connective tissues, it is composed of eighteen amino acids. The properties and functions of gelatin when it acts as a polydisperse polymer make it extensively applicable to the pharma and food industries.
With the rising demand for capsules across the world, gelatin has become an ingredient without which it is hard for pharma and many food industries to survive. Be it in the manufacturing of capsules or tablets or as a component of wound dressings, hemostatic sponges, or blood volume replacement; gelatin has shown its versatility in applicability in the medicine and pharmaceutical industry.
In the production of hard capsules and soft-gels; gelatin is used as an inactive substance that serves as a medium for an active substance. The cost associated with the production of gelatin is significantly less, and the process of making gelatin is not much complex. Also, it has active pharmaceutical ingredient (API) dissolution rates.
Pharmaceutical gelatin provides various technical benefits as compared to excipients such as HMPC, made for hard capsules, and modified starch for soft-gels. Additionally, it comes without an e-number, making it a unique excipient. Following ISO technical specifications on definitions and technical criteria, gelatin is considered a natural ingredient. It is also used in the manufacturing of medical devices.
COVID-19 Impact Analysis
The unprecedented pandemic proved to be a pause in the demand for gelatin which experienced declining anticipated demand across the nations. The outbreak of coronavirus resulted in a sudden diminish in the market and sale of the products. The growing awareness of staying healthy and being fit thrived the market for supplements, which pushed the demand for supplements to a high level. It also provided support to manufacturers to produce capsules to fulfill the needs of the market. These immunity-building products, such as nutritional supplements, are the major drivers for the surging demand.Market Growth Factors
Increased use as remedy for hair loss
Rising awareness about gelatin-based products, which have the potential to make the hair texture better and improve the quality of hair, is expected to boost the demand for these products. Gelatin consists of proteins that bond easily, which is not possible for a protein found in egg yolk. Gelatin works on the damaged areas and provides nourishment to the entire strand of hair. It smoothens the hair cuticle, maintains shine, and helps in the reduction of any breakage.Rising health consciousness among people
Rising health consciousness among the public is one of the factors to propel the demand for supplements. Therefore, major players in the market are focusing on making new developments in producing soft-gels to offer to consumers. This factor is helping to uplift the market growth. An increase in the number of sports and fitness gyms is boosting the demand for nutritious supplements which uses gelatin as one of the components.Market Restraining Factors
Cost Variability and High Prices
The shift in the price of soft gelatin capsules occurs quite frequently and, thus, hampers the expansion of the market. Furthermore, the high costs of vegetarian capsules present a significant barrier to the gelatin used. Several other factors, like soft gel capsules’ low stability, particularly those having water-soluble chemicals, limited gelatin-compatible excipient choice for soft-gels, and special manufacturing processes requirement, also influence the adoption of gelatin for producing soft-gels.Type Outlook
By type, the pharmaceutical gelatin market is segmented into Type A and Type B. The type A segment registered a remarkable revenue share in the pharmaceutical gelatin market in 2021. This is due to its derivation from pig skin, which is more resistant to acid hydrolysis during long-term storage when compared to other forms of gelatin.
Source Outlook
By source, the pharmaceutical gelatin market is fragmented into porcine, bovine skin, bovine bone, marine and poultry. The porcine segment generated the highest revenue share in the pharmaceutical gelatin market in 2021. The growth is attributed to using porcine gelatin to coat glass-bottomed plates for culturing A375 cells. It is also used in gelatin degradation assay, for coating glass slides in histological studies with brain sections, and in making thiol-functionalized gelatin (GelSH) hydrogel for 3D projection bioprinting.Function Outlook
By function, the pharmaceutical gelatin market is classified into stabilizing agent, thickening agent, gelling agent & other. The gelling agent segment procured a prominent revenue share in the pharmaceutical gelatin market in 2021. Gelling agents are used to improving the thickness or viscosity of the formulation, enhance the nasal retention time and restrict the spillage from the nasal cavity via mucociliary clearance and gravitational forces.Application Outlook
Based on application, the pharmaceutical gelatin market is segmented into hard capsules, softgel capsules, tablets, absorbable hemostats and others. In 2021, the hard capsules segment recorded a highest revenue share in the pharmaceutical gelatin market. This is due to functional capabilities of gelatin as well as the rising prevalence of chronic diseases like cancer, CVD and others.Regional Outlook
Region wise, the pharmaceutical gelatin market is analyzed across North America, Europe, Asia Pacific, LAMEA. In 2021, the North America region led the pharmaceutical gelatin market with the highest revenue share. Consumers across the region opt for natural protein sources like gelatin for hair and skin health instead of catalysts claiming equal potential. Due to this, the demand for pharmaceutical gelatin is accelerating. Thereby leading to the expansion of the pharmaceutical gelatin market’s expansion.The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
Strategies Deployed in Pharmaceutical Gelatin Market
- May-2022: Capsugel introduced titanium dioxide-free (TiO2-free) white hard gelatin capsule under its already existing titanium dioxide-free capsule range. The new titanium dioxide-free capsule is based on crystallized salts to deliver the same masking and whiteness as capsules with TiO2. The product features superb opacity and light protection.
- Jan-2022: Rousselot, part of Darling Ingredients partnered with Terasaki Institute for Biomedical Innovation (TIBI), a US-based research institute. The partnership involves working together on the advancement of gelatin-based therapies. Moreover, Roussselot’s X-Pure modified gelatin range would be the perfect fit for biomedical research and the following clinical translation.
- May-2021: Rousselot, a brand under Darling Ingredients introduced X-Pure® GelDAT, the first phenol-functionalized and purified gelatin. The new product expands Rousselot"s gelatin product offerings, and further opens up opportunities for innovations.
- Jan-2021: Nitta introduced international standard gelatin intended for food fanatics. The fine-quality gelatin is based on Japanese technology and caters to the needs of the Hotel/Restaurant/Catering (HoReCa) sector.
- Dec-2020: GELITA acquired 65% ownership in SelJel, a Turkish producer of gelatine. This acquisition strengthens Gelita"s market position and complements Gelita"s product portfolio. The acquisition further enables Gelita to serve the growing demand for products with halal status.
- Oct-2020: Catalent introduced OptiGel® DR technology intended for manufacturing delayed/enteric release soft gels. The OptiGel DR technology allows soft gels to be formed by integrating pectin, and gelatin. The OptiGel DR capsules feature reduced gastric reflux effects and eradicate the processing and performance challenges. Additionally, the innovation of OptiGel DR technology enables innovators to design efficient products and further reduces yield loss and time-related to coated softgels.
- Sep-2020: Gelita came into partnership with Azelis, a Belgium-based service provider for the food ingredients and specialty chemicals industry. The partnership involves entrusting Azelis with the distribution of all gelatin products in France. Additionally, the partnership benefits Gelita by cashing on Azelis" large customer base.
- May-2019: Tessenderlo Group launched ClaroBGI600, the first product in the Claro series. ClaroBGI600 is a gelatin intended to use in bio-ink formulations and comes with a verified printing time of up to 2 hours. The new product solves printer clogging issues and reduces the cost of designing 3D-printed tissues.
Scope of the Study
By Type
- Type B
- Type A
By Source
- Porcine
- Bovine Skin
- Bovine Bone
- Marine
- Poultry
By Function
- Stabilizing Agent
- Thickening Agent
- Gelling Agent & Others
By Application
- Hard Capsules
- Softgel Capsules
- Tablets
- Absorbable Hemostats
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- Egypt
- Tanzania
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Darling Ingredients, Inc.
- Nitta Gelatin, Inc.
- Tessenderlo Group nv
- Gelita AG
- SAS Gelatines Weishardt
- Lonza Group Ltd. (Capsugel)
- Norland Products, Inc.
- Roxlor Group
- Catalent, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Pharmaceutical Gelatin Market, by Type
1.4.2 Global Pharmaceutical Gelatin Market, by Source
1.4.3 Global Pharmaceutical Gelatin Market, by Function
1.4.4 Global Pharmaceutical Gelatin Market, by Application
1.4.5 Global Pharmaceutical Gelatin Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Pharmaceutical Gelatin Market
Chapter 4. Global Pharmaceutical Gelatin Market by Type
4.1 Global Type B Market by Region
4.2 Global Type A Market by Region
Chapter 5. Global Pharmaceutical Gelatin Market by Source
5.1 Global Porcine Market by Region
5.2 Global Bovine Skin Market by Region
5.3 Global Bovine Bone Market by Region
5.4 Global Marine Market by Region
5.5 Global Poultry Market by Region
Chapter 6. Global Pharmaceutical Gelatin Market by Function
6.1 Global Stabilizing Agent Market by Region
6.2 Global Thickening Agent Market by Region
6.3 Global Gelling Agent & Others Market by Region
Chapter 7. Global Pharmaceutical Gelatin Market by Application
7.1 Global Hard Capsules Market by Region
7.2 Global Softgel Capsules Market by Region
7.3 Global Tablets Market by Region
7.4 Global Absorbable Hemostats Market by Region
7.5 Global Others Market by Region
Chapter 8. Global Pharmaceutical Gelatin Market by Region
8.1 North America Pharmaceutical Gelatin Market
8.1.1 North America Pharmaceutical Gelatin Market by Type
8.1.1.1 North America Type B Market by Country
8.1.1.2 North America Type A Market by Country
8.1.2 North America Pharmaceutical Gelatin Market by Source
8.1.2.1 North America Porcine Market by Country
8.1.2.2 North America Bovine Skin Market by Country
8.1.2.3 North America Bovine Bone Market by Country
8.1.2.4 North America Marine Market by Country
8.1.2.5 North America Poultry Market by Country
8.1.3 North America Pharmaceutical Gelatin Market by Function
8.1.3.1 North America Stabilizing Agent Market by Country
8.1.3.2 North America Thickening Agent Market by Country
8.1.3.3 North America Gelling Agent & Others Market by Country
8.1.4 North America Pharmaceutical Gelatin Market by Application
8.1.4.1 North America Hard Capsules Market by Country
8.1.4.2 North America Softgel Capsules Market by Country
8.1.4.3 North America Tablets Market by Country
8.1.4.4 North America Absorbable Hemostats Market by Country
8.1.4.5 North America Others Market by Country
8.1.5 North America Pharmaceutical Gelatin Market by Country
8.1.5.1 US Pharmaceutical Gelatin Market
8.1.5.1.1 US Pharmaceutical Gelatin Market by Type
8.1.5.1.2 US Pharmaceutical Gelatin Market by Source
8.1.5.1.3 US Pharmaceutical Gelatin Market by Function
8.1.5.1.4 US Pharmaceutical Gelatin Market by Application
8.1.5.2 Canada Pharmaceutical Gelatin Market
8.1.5.2.1 Canada Pharmaceutical Gelatin Market by Type
8.1.5.2.2 Canada Pharmaceutical Gelatin Market by Source
8.1.5.2.3 Canada Pharmaceutical Gelatin Market by Function
8.1.5.2.4 Canada Pharmaceutical Gelatin Market by Application
8.1.5.3 Mexico Pharmaceutical Gelatin Market
8.1.5.3.1 Mexico Pharmaceutical Gelatin Market by Type
8.1.5.3.2 Mexico Pharmaceutical Gelatin Market by Source
8.1.5.3.3 Mexico Pharmaceutical Gelatin Market by Function
8.1.5.3.4 Mexico Pharmaceutical Gelatin Market by Application
8.1.5.4 Rest of North America Pharmaceutical Gelatin Market
8.1.5.4.1 Rest of North America Pharmaceutical Gelatin Market by Type
8.1.5.4.2 Rest of North America Pharmaceutical Gelatin Market by Source
8.1.5.4.3 Rest of North America Pharmaceutical Gelatin Market by Function
8.1.5.4.4 Rest of North America Pharmaceutical Gelatin Market by Application
8.2 Europe Pharmaceutical Gelatin Market
8.2.1 Europe Pharmaceutical Gelatin Market by Type
8.2.1.1 Europe Type B Market by Country
8.2.1.2 Europe Type A Market by Country
8.2.2 Europe Pharmaceutical Gelatin Market by Source
8.2.2.1 Europe Porcine Market by Country
8.2.2.2 Europe Bovine Skin Market by Country
8.2.2.3 Europe Bovine Bone Market by Country
8.2.2.4 Europe Marine Market by Country
8.2.2.5 Europe Poultry Market by Country
8.2.3 Europe Pharmaceutical Gelatin Market by Function
8.2.3.1 Europe Stabilizing Agent Market by Country
8.2.3.2 Europe Thickening Agent Market by Country
8.2.3.3 Europe Gelling Agent & Others Market by Country
8.2.4 Europe Pharmaceutical Gelatin Market by Application
8.2.4.1 Europe Hard Capsules Market by Country
8.2.4.2 Europe Softgel Capsules Market by Country
8.2.4.3 Europe Tablets Market by Country
8.2.4.4 Europe Absorbable Hemostats Market by Country
8.2.4.5 Europe Others Market by Country
8.2.5 Europe Pharmaceutical Gelatin Market by Country
8.2.5.1 Germany Pharmaceutical Gelatin Market
8.2.5.1.1 Germany Pharmaceutical Gelatin Market by Type
8.2.5.1.2 Germany Pharmaceutical Gelatin Market by Source
8.2.5.1.3 Germany Pharmaceutical Gelatin Market by Function
8.2.5.1.4 Germany Pharmaceutical Gelatin Market by Application
8.2.5.2 UK Pharmaceutical Gelatin Market
8.2.5.2.1 UK Pharmaceutical Gelatin Market by Type
8.2.5.2.2 UK Pharmaceutical Gelatin Market by Source
8.2.5.2.3 UK Pharmaceutical Gelatin Market by Function
8.2.5.2.4 UK Pharmaceutical Gelatin Market by Application
8.2.5.3 France Pharmaceutical Gelatin Market
8.2.5.3.1 France Pharmaceutical Gelatin Market by Type
8.2.5.3.2 France Pharmaceutical Gelatin Market by Source
8.2.5.3.3 France Pharmaceutical Gelatin Market by Function
8.2.5.3.4 France Pharmaceutical Gelatin Market by Application
8.2.5.4 Russia Pharmaceutical Gelatin Market
8.2.5.4.1 Russia Pharmaceutical Gelatin Market by Type
8.2.5.4.2 Russia Pharmaceutical Gelatin Market by Source
8.2.5.4.3 Russia Pharmaceutical Gelatin Market by Function
8.2.5.4.4 Russia Pharmaceutical Gelatin Market by Application
8.2.5.5 Spain Pharmaceutical Gelatin Market
8.2.5.5.1 Spain Pharmaceutical Gelatin Market by Type
8.2.5.5.2 Spain Pharmaceutical Gelatin Market by Source
8.2.5.5.3 Spain Pharmaceutical Gelatin Market by Function
8.2.5.5.4 Spain Pharmaceutical Gelatin Market by Application
8.2.5.6 Italy Pharmaceutical Gelatin Market
8.2.5.6.1 Italy Pharmaceutical Gelatin Market by Type
8.2.5.6.2 Italy Pharmaceutical Gelatin Market by Source
8.2.5.6.3 Italy Pharmaceutical Gelatin Market by Function
8.2.5.6.4 Italy Pharmaceutical Gelatin Market by Application
8.2.5.7 Rest of Europe Pharmaceutical Gelatin Market
8.2.5.7.1 Rest of Europe Pharmaceutical Gelatin Market by Type
8.2.5.7.2 Rest of Europe Pharmaceutical Gelatin Market by Source
8.2.5.7.3 Rest of Europe Pharmaceutical Gelatin Market by Function
8.2.5.7.4 Rest of Europe Pharmaceutical Gelatin Market by Application
8.3 Asia Pacific Pharmaceutical Gelatin Market
8.3.1 Asia Pacific Pharmaceutical Gelatin Market by Type
8.3.1.1 Asia Pacific Type B Market by Country
8.3.1.2 Asia Pacific Type A Market by Country
8.3.2 Asia Pacific Pharmaceutical Gelatin Market by Source
8.3.2.1 Asia Pacific Porcine Market by Country
8.3.2.2 Asia Pacific Bovine Skin Market by Country
8.3.2.3 Asia Pacific Bovine Bone Market by Country
8.3.2.4 Asia Pacific Marine Market by Country
8.3.2.5 Asia Pacific Poultry Market by Country
8.3.3 Asia Pacific Pharmaceutical Gelatin Market by Function
8.3.3.1 Asia Pacific Stabilizing Agent Market by Country
8.3.3.2 Asia Pacific Thickening Agent Market by Country
8.3.3.3 Asia Pacific Gelling Agent & Others Market by Country
8.3.4 Asia Pacific Pharmaceutical Gelatin Market by Application
8.3.4.1 Asia Pacific Hard Capsules Market by Country
8.3.4.2 Asia Pacific Softgel Capsules Market by Country
8.3.4.3 Asia Pacific Tablets Market by Country
8.3.4.4 Asia Pacific Absorbable Hemostats Market by Country
8.3.4.5 Asia Pacific Others Market by Country
8.3.5 Asia Pacific Pharmaceutical Gelatin Market by Country
8.3.5.1 China Pharmaceutical Gelatin Market
8.3.5.1.1 China Pharmaceutical Gelatin Market by Type
8.3.5.1.2 China Pharmaceutical Gelatin Market by Source
8.3.5.1.3 China Pharmaceutical Gelatin Market by Function
8.3.5.1.4 China Pharmaceutical Gelatin Market by Application
8.3.5.2 Japan Pharmaceutical Gelatin Market
8.3.5.2.1 Japan Pharmaceutical Gelatin Market by Type
8.3.5.2.2 Japan Pharmaceutical Gelatin Market by Source
8.3.5.2.3 Japan Pharmaceutical Gelatin Market by Function
8.3.5.2.4 Japan Pharmaceutical Gelatin Market by Application
8.3.5.3 India Pharmaceutical Gelatin Market
8.3.5.3.1 India Pharmaceutical Gelatin Market by Type
8.3.5.3.2 India Pharmaceutical Gelatin Market by Source
8.3.5.3.3 India Pharmaceutical Gelatin Market by Function
8.3.5.3.4 India Pharmaceutical Gelatin Market by Application
8.3.5.4 Australia Pharmaceutical Gelatin Market
8.3.5.4.1 Australia Pharmaceutical Gelatin Market by Type
8.3.5.4.2 Australia Pharmaceutical Gelatin Market by Source
8.3.5.4.3 Australia Pharmaceutical Gelatin Market by Function
8.3.5.4.4 Australia Pharmaceutical Gelatin Market by Application
8.3.5.5 South Korea Pharmaceutical Gelatin Market
8.3.5.5.1 South Korea Pharmaceutical Gelatin Market by Type
8.3.5.5.2 South Korea Pharmaceutical Gelatin Market by Source
8.3.5.5.3 South Korea Pharmaceutical Gelatin Market by Function
8.3.5.5.4 South Korea Pharmaceutical Gelatin Market by Application
8.3.5.6 Malaysia Pharmaceutical Gelatin Market
8.3.5.6.1 Malaysia Pharmaceutical Gelatin Market by Type
8.3.5.6.2 Malaysia Pharmaceutical Gelatin Market by Source
8.3.5.6.3 Malaysia Pharmaceutical Gelatin Market by Function
8.3.5.6.4 Malaysia Pharmaceutical Gelatin Market by Application
8.3.5.7 Rest of Asia Pacific Pharmaceutical Gelatin Market
8.3.5.7.1 Rest of Asia Pacific Pharmaceutical Gelatin Market by Type
8.3.5.7.2 Rest of Asia Pacific Pharmaceutical Gelatin Market by Source
8.3.5.7.3 Rest of Asia Pacific Pharmaceutical Gelatin Market by Function
8.3.5.7.4 Rest of Asia Pacific Pharmaceutical Gelatin Market by Application
8.4 LAMEA Pharmaceutical Gelatin Market
8.4.1 LAMEA Pharmaceutical Gelatin Market by Type
8.4.1.1 LAMEA Type B Market by Country
8.4.1.2 LAMEA Type A Market by Country
8.4.2 LAMEA Pharmaceutical Gelatin Market by Source
8.4.2.1 LAMEA Porcine Market by Country
8.4.2.2 LAMEA Bovine Skin Market by Country
8.4.2.3 LAMEA Bovine Bone Market by Country
8.4.2.4 LAMEA Marine Market by Country
8.4.2.5 LAMEA Poultry Market by Country
8.4.3 LAMEA Pharmaceutical Gelatin Market by Function
8.4.3.1 LAMEA Stabilizing Agent Market by Country
8.4.3.2 LAMEA Thickening Agent Market by Country
8.4.3.3 LAMEA Gelling Agent & Others Market by Country
8.4.4 LAMEA Pharmaceutical Gelatin Market by Application
8.4.4.1 LAMEA Hard Capsules Market by Country
8.4.4.2 LAMEA Softgel Capsules Market by Country
8.4.4.3 LAMEA Tablets Market by Country
8.4.4.4 LAMEA Absorbable Hemostats Market by Country
8.4.4.5 LAMEA Others Market by Country
8.4.5 LAMEA Pharmaceutical Gelatin Market by Country
8.4.5.1 Brazil Pharmaceutical Gelatin Market
8.4.5.1.1 Brazil Pharmaceutical Gelatin Market by Type
8.4.5.1.2 Brazil Pharmaceutical Gelatin Market by Source
8.4.5.1.3 Brazil Pharmaceutical Gelatin Market by Function
8.4.5.1.4 Brazil Pharmaceutical Gelatin Market by Application
8.4.5.2 Argentina Pharmaceutical Gelatin Market
8.4.5.2.1 Argentina Pharmaceutical Gelatin Market by Type
8.4.5.2.2 Argentina Pharmaceutical Gelatin Market by Source
8.4.5.2.3 Argentina Pharmaceutical Gelatin Market by Function
8.4.5.2.4 Argentina Pharmaceutical Gelatin Market by Application
8.4.5.3 Egypt Pharmaceutical Gelatin Market
8.4.5.3.1 Egypt Pharmaceutical Gelatin Market by Type
8.4.5.3.2 Egypt Pharmaceutical Gelatin Market by Source
8.4.5.3.3 Egypt Pharmaceutical Gelatin Market by Function
8.4.5.3.4 Egypt Pharmaceutical Gelatin Market by Application
8.4.5.4 Tanzania Pharmaceutical Gelatin Market
8.4.5.4.1 Tanzania Pharmaceutical Gelatin Market by Type
8.4.5.4.2 Tanzania Pharmaceutical Gelatin Market by Source
8.4.5.4.3 Tanzania Pharmaceutical Gelatin Market by Function
8.4.5.4.4 Tanzania Pharmaceutical Gelatin Market by Application
8.4.5.5 South Africa Pharmaceutical Gelatin Market
8.4.5.5.1 South Africa Pharmaceutical Gelatin Market by Type
8.4.5.5.2 South Africa Pharmaceutical Gelatin Market by Source
8.4.5.5.3 South Africa Pharmaceutical Gelatin Market by Function
8.4.5.5.4 South Africa Pharmaceutical Gelatin Market by Application
8.4.5.6 Nigeria Pharmaceutical Gelatin Market
8.4.5.6.1 Nigeria Pharmaceutical Gelatin Market by Type
8.4.5.6.2 Nigeria Pharmaceutical Gelatin Market by Source
8.4.5.6.3 Nigeria Pharmaceutical Gelatin Market by Function
8.4.5.6.4 Nigeria Pharmaceutical Gelatin Market by Application
8.4.5.7 Rest of LAMEA Pharmaceutical Gelatin Market
8.4.5.7.1 Rest of LAMEA Pharmaceutical Gelatin Market by Type
8.4.5.7.2 Rest of LAMEA Pharmaceutical Gelatin Market by Source
8.4.5.7.3 Rest of LAMEA Pharmaceutical Gelatin Market by Function
8.4.5.7.4 Rest of LAMEA Pharmaceutical Gelatin Market by Application
Chapter 9. Company Profiles
9.1 Nitta Gelatin, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Sales Category and Regional Analysis
9.1.4 Recent strategies and developments:
9.1.4.1 Product Launches and Product Expansions:
9.2 Tessenderlo Group nv
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.3 Lonza Group Ltd. (Capsugel)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:’
9.4 Catalent, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 Darling Ingredients, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Partnerships, Collaborations, and Agreements:
9.5.4.2 Product Launches and Product Expansions:
9.6 GELITA AG
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.6.2.2 Acquisition and Mergers:
9.7 Roxlor Group
9.7.1 Company Overview
9.8 Norland Products, Inc.
9.8.1 Company Overview
9.9 SAS Gelatines Weishardt
9.9.1 Company Overview
Companies Mentioned
- Darling Ingredients, Inc.
- Nitta Gelatin, Inc.
- Tessenderlo Group nv
- Gelita AG
- SAS Gelatines Weishardt
- Lonza Group Ltd. (Capsugel)
- Norland Products, Inc.
- Roxlor Group
- Catalent, Inc.
Methodology
LOADING...
